Journal profile · Nursing-Oncology (nursing)
Seminars in Oncology Nursing
ISSN 0749-2081 · eISSN 1878-3449 · W.B. Saunders Ltd · United Kingdom
Seminars in Oncology Nursing: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.11; hybrid open access; APC about USD 3,590; median 128 days to acceptance (104 articles, last 24 months); 154 articles in 2025; indexed in SCIE, SSCI and Scopus.
Scope
Aims, scope and focus
Seminars in Oncology Nursing is published by W.B. Saunders Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer survivorship and care, Childhood Cancer Survivors' Quality of Life and Palliative Care and End-of-Life Issues, together about 37.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Seminars in Oncology Nursing (SON) is a unique, international peer-reviewed journal, published six times a year. It features special issues that offer a multi-faceted overview of a contemporary cancer topic, relevant to patient care, nursing education, management, and/or policy development. Each special issue is led by Guest Editors who solicit articles from invited expert authors. In addition to solicited articles, the Editor-in-Chief welcomes the submission of unsolicited original research and review articles. SON publishes on all aspects of cancer nursing, whether in the field of research, practice, or education.
From the journal's Aims & Scope
Research area (LetPub): Nursing-Oncology (nursing)
Editor-in-chief Grigorios KotronoulasPublisher website
Editorial board by country: none in mainland China; most named United States 10, United Kingdom 10, Australia 6, Ireland 4, Canada 2 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer survivorship and careMedicine19.1%
- Childhood Cancer Survivors' Quality of LifeMedicine9.4%
- Palliative Care and End-of-Life IssuesMedicine8.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7%
- Cancer-related cognitive impairment studiesMedicine4.3%
- Human auditory perception and evaluationEngineering4.1%
- Global Cancer Incidence and ScreeningMedicine3.6%
- Family Support in IllnessSocial Sciences3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Nursing | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Nursing | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Nursing | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
Database indexing
SCIESSCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.11LetPub ·
- Impact factor (publisher)
- 3.2Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- SJR 2026-06
- 0.73LetPub ·
- SNIP 2026-06
- 0.98LetPub ·
- h-index
- 41LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 945OpenAlex ·
- 2-year mean citedness
- 2.61OpenAlex ·
- Self-citation rate
- 6.2%LetPub ·
- Share of gold OA articles
- 40.28%LetPub ·
Volume
- Articles per year
- 125LetPub ·
Articles by year OpenAlex count · 2,785 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 104 | 37 | 18 |
| 2025 | 154 | 60 | 264 |
| 2024 | 154 | 73 | 795 |
| 2023 | 128 | 65 | 1,133 |
| 2022 | 83 | 22 | 837 |
| 2021 | 94 | 17 | 1,230 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
128 daysMedian, submission to acceptance · P25–P75 99 days – 182 days
- Acceptance to online
- median 28 days (104 articles)
- Submission to online
- median 160 days
- Sample
- 104 articles with submission and acceptance dates (273 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 17 daysPublisher website ·
- First decision after review
- 55 daysPublisher website ·
- Submission to acceptance
- 83 daysPublisher website ·
- Acceptance to publication
- 28 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,590 / EUR 3,360 / GBP 2,870 / JPY 445,270 | — | — | |
| Publisher website | USD 3,410 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteArticle types accepted4
- discussion paperArticle types Original article, Review, Discussion paper, and Letter to the Editor.Length not stated
- letter to the editorOriginal article, Review, Discussion paper, and Letter to the Editor.Length not stated
- original articleOriginal article, Review, Discussion paper, and Letter to the Editor.Length not stated
- reviewOriginal article, Review, Discussion paper, and Letter to the Editor.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting Guidelines
The Editor-in-Chief requires that manuscripts adhere to recognized reporting guidelines relevant to the research design used. Authors are required to submit a checklist verifying that essential elements have been reported for all primary research and evidence synthesis work. A non-exhaustive list of reporting guidelines endorsed by the journal are listed below – for additional information, please …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- W.B. Saunders Ltd
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 0749-2081
- Electronic ISSN
- 1878-3449
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Oncology Nursing
What CAS zone is Seminars in Oncology Nursing in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Oncology Nursing is in Zone 3 of Medicine, and in Zone 2 of the minor category Nursing / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Oncology Nursing?
The latest impact factor listed by LetPub is 3.11; CiteScore 3.9, h-index 83.
How long does peer review take at Seminars in Oncology Nursing?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 99–182 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Seminars in Oncology Nursing based?
Of the 48 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (10), United Kingdom (10) and Australia (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Oncology Nursing?
According to LetPub and DOAJ records, Seminars in Oncology Nursing is indexed in SCIE, SSCI and Scopus.
Is Seminars in Oncology Nursing open access, and what is the APC?
Seminars in Oncology Nursing is a hybrid journal. For open-access publication: APC about USD 3,590.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .